
Sign up to save your podcasts
Or


Interview with Sarat Chandarlapaty, MD, PhD, author of Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial
By JAMA Network3.8
1111 ratings
Interview with Sarat Chandarlapaty, MD, PhD, author of Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial

320 Listeners

496 Listeners

40 Listeners

163 Listeners

57 Listeners

112,574 Listeners

38 Listeners

56,419 Listeners

21 Listeners

12 Listeners

8 Listeners

16 Listeners

18 Listeners

5 Listeners

6 Listeners

44 Listeners

29 Listeners

9 Listeners

90 Listeners

14 Listeners

5 Listeners

5 Listeners

106 Listeners

19 Listeners

14,605 Listeners

3 Listeners

1,227 Listeners